IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Dcvc Opportunity Fund II GP, LLC

Q1 2025 Holdings

Filed 2025-05-15 | 2 holdings | $81.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Rocket Lab USA, Inc.COM773122106$60.6M3,388,24974.3%
Recursion Pharmaceuticals, Inc.(RXRX)CL A75629V104$20.9M3,951,14125.7%